Ceo
CurrentNKore is a cellular-based biotherapeutics business focused on the diagnosis and treatment of cancer. NKore's IP portfolio includes a robust diagnostic platform to measure the cellular function of the immune system and a proprietary approach to activating or "supercharging" the immune system to deliver more effective, less toxic treatment options for cancer patients.